Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
22 Julio 2024 - 3:05PM
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it
will report second quarter financial results and provide a
corporate update on July 29, 2024. The company will also host a
conference call that day at 5:00 p.m. Eastern Time (2:00 p.m.
Pacific Time).
Conference Call Information
Participants must register in advance of the
conference call by clicking here. Upon registering, each
participant will receive a dial-in number, and a unique access PIN.
Each access PIN will accommodate one caller.
Additionally, a listen-only webcast will be
available by clicking here.
A replay of the call will be available on the
Investors / Events tab of Corcept.com.
About Corcept Therapeutics
For over 25 years, Corcept’s focus on cortisol
modulation and its potential to treat patients with a wide variety
of serious disorders has led to the discovery of more than 1,000
proprietary selective cortisol modulators. Corcept is conducting
advanced clinical trials in patients with hypercortisolism, solid
tumors, amyotrophic lateral sclerosis (ALS) and liver disease. In
February 2012, the company introduced Korlym®, the first medication
approved by the U.S. Food and Drug Administration for the treatment
of patients with Cushing’s syndrome. Corcept is headquartered in
Menlo Park, California. For more information, visit
Corcept.com.
CONTACT:Investor
inquiries:ir@corcept.comMedia
inquiries:communications@corcept.comwww.corcept.com
Corcept Therapeutics (NASDAQ:CORT)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Corcept Therapeutics (NASDAQ:CORT)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024